![Virginia R. Dean](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Virginia R. Dean
Personalreferent bei
Obsidian Therapeutics, Inc.
Profil
Virginia R.
Dean currently works at Obsidian Therapeutics, Inc., as Senior Vice President-Human Resources.
Ms. Dean also formerly worked at Macromedia, Inc., as Director-Human Resources from 2001 to 2004, FleetBoston Financial Corp., as Director-Compensation & Commercial Banks in 2001, The Bridgespan Group, as Director-Human Resources from 2004 to 2007, ARIAD Pharmaceuticals, Inc., as Vice President-Human Resources, Allaire Corp, as Vice President-Human Resources from 2000 to 2001, Acronis AG, as Global Vice President-Human Resources, Tesaro, Inc., as Vice President-Human Resources, Oculis Holding AG, as Chief Human Resources Officer from 2024 to 2025, and Axcella Health, Inc., as Chief People Officer & Senior Vice President.
Ms. Dean received her Masters Business Admin degree from Simmons University and undergraduate degree from the University of Vermont.
Aktive Positionen von Virginia R. Dean
| Unternehmen | Position | Beginn |
|---|---|---|
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Personalreferent | - |
Ehemalige bekannte Positionen von Virginia R. Dean
| Unternehmen | Position | Ende |
|---|---|---|
| OCULIS HOLDING AG | Personalreferent | 01.02.2025 |
| AXCA HEALPAR | Personalreferent | 14.12.2022 |
The Bridgespan Group
 The Bridgespan Group Miscellaneous Commercial ServicesCommercial Services Provides management strategies and tools | Personalreferent | 01.01.2007 |
Macromedia, Inc.
 Macromedia, Inc. Packaged SoftwareTechnology Services Provides software technologies and internet solutions | Personalreferent | 01.01.2004 |
Allaire Corp
 Allaire Corp Packaged SoftwareTechnology Services Develops, markets and supports software for Web development applications | Personalreferent | 01.01.2001 |
Ausbildung von Virginia R. Dean
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
80
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Macromedia, Inc.
Macromedia, Inc. Packaged SoftwareTechnology Services Provides software technologies and internet solutions | Technology Services |
Allaire Corp
Allaire Corp Packaged SoftwareTechnology Services Develops, markets and supports software for Web development applications | Technology Services |
FleetBoston Financial Corp.
 FleetBoston Financial Corp. Major BanksFinance Individually managed equity portfolios emphasize long-term growth and are constructed from a list of between 30 and 50 stocks carefully selected from a universe of about 300 companies. Typically large capitalization, these stocks are identified through a process that combines bottom-up company-by-company analysis with top-down screening. Approved stocks are combined in a portfolio that is deliberately diversified across economic sectors to manage risk while capitalizing on long-term economic expectations and demographic trends. Equities: The firm methodology for equities investing includes a systematic analysis of macroeconomic conditions. To be included in a portfolio a company must: 1) have historically low relative p/e ratio of stock to industry, stock to market and stock to GNP; 2) be growing at a rate greater than its current p/e multiple; 3) have a strong cash flow; 4) have increasing levels of dividends. Stocks are sold when they reach an extreme in the established price range, the fundamentals deteriorate, or there are more compelling buying opportunities available. Balanced & Fixed: The firm uses a combination of economic, international, and political analysis to begin to determine the proper asset allocation between fixed-income and equity investments. Fixed-income parameters are based upon forecasts of trends in economics and interest rates and other technical considerations. The equity portion of the portfolio is determined by establishing a likely range for the market based upon forecasts of earnings, inflation, and corporate price-earnings. In addition, consideration is given to the clients' investment objectives. | Finance |
Acronis AG
 Acronis AG Packaged SoftwareTechnology Services Provides AI-powered backup and cyber security & data protection software solutions | Technology Services |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
Simmons University
 Simmons University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Bridgespan Group
The Bridgespan Group Miscellaneous Commercial ServicesCommercial Services Provides management strategies and tools | Commercial Services |
Axcella Health, Inc.
 Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
Oculis Holding AG
 Oculis Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a global biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases | Commercial Services |
